Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
21MT-1
HER2amp
-
Mebendazole
13719.174
uM
31.97060
77.55140
0.0875 -1.0000 1.2398 0.1610
0.8782
0.8124
21MT-1
HER2amp
-
Methylglyoxal
13719.184
uM
680.32080
999.99990
-0.9954 -0.9645 2.7899 0.6345
0.9961
0.7600
21MT-1
HER2amp
-
MG-132
Proteasome
Proteasome
14191.189
uM
inf
inf
-0.1161 -0.1161 0.0000 0.5482
0.5418
2.9704
21MT-1
HER2amp
-
MG-132
Proteasome
Proteasome
14191.189
uM
inf
inf
-0.1161 -0.1161 0.0000 0.5482
0.5418
2.9704
184A1
NM
Basal
Taxol
TUBB
TUBB
9047.002
uM
0.05134
0.13706
-0.1958 -0.2758 0.4473 0.5388
0.9220
0.5243
184A1
NM
Basal
GSK461364
PLK1
PLK
10002.001
uM
6.06620
9.11620
-0.9717 -1.0000 2.6972 0.2605
0.9735
0.5372
184B5
NM
Basal
QNZ
NFkB
NFKB
5897.096
uM
0.03394
0.04191
-0.9427 -0.9339 4.9999 1.0267
0.9995
1.2810
184B5
NM
Basal
Purvalanol A
CDK1
CDK
5897.067
uM
12.87360
13.92180
-0.3686 -0.2376 4.9663 0.2133
0.9779
1.1908
184A1
NM
Basal
TAPI-0
TACE/Collagenase
5895.096
uM
inf
6.62580
0.8804 0.8803 5.0000 -0.0065
0.5959
1.4232
184B5
NM
Basal
Purvalanol A
CDK1
CDK
5896.067
uM
2.11650
1.66090
0.2353 0.3509 4.9920 0.2073
0.9594
1.4536
184B5
NM
Basal
PS-1145
IKK
NFKB
5897.065
uM
inf
inf
0.9561 0.9561 0.0000 0.0500
0.3340
1.2996
184A1
NM
Basal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
5895.067
uM
5.42490
7.97390
-0.9135 -0.9079 2.6878 0.4188
0.9982
1.4053
184A1
NM
Basal
GSK461364
PLK1
PLK
9047.001
uM
4.15810
52.44110
-0.0073 -1.0000 0.4334 0.2620
0.7464
0.7701
184A1
NM
Basal
Dichloroacetate
PDK
PDK
12684.176
uM
inf
inf
0.9148 0.9148 0.0000 0.0449
0.1851
1.3650
184B5
NM
Basal
PS-1145
IKK
NFKB
5896.065
uM
inf
inf
0.9046 0.9046 0.0000 0.0309
0.3134
1.4978
184B5
NM
Basal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5897.095
uM
0.52125
0.66097
-0.3237 -0.3105 2.0341 0.8593
0.9969
1.2197
184A1
NM
Basal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
5894.067
uM
4.440
8.19730
-0.9413 -0.9957 1.7870 0.4582
0.9949
1.5647
184B5
NM
Basal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5896.095
uM
0.24202
0.32119
-0.2838 -0.2743 1.5454 0.9106
0.9931
1.5532
184B5
NM
Basal
PD184352
MEK
MAPK
12566.155
uM
3.29320
33.01680
-0.0750 -1.0000 0.4766 0.2503
0.9170
1.5389
184A1
NM
Basal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
5894.084
uM
3.93680
6.19440
-0.5995 -0.4573 1.4330 0.5586
0.9851
1.5903
184A1
NM
Basal
GSK1838705A
IGF1R
RTK
5894.098
uM
0.36902
0.35227
0.0333 0.0487 2.2061 0.3782
0.9970
1.6523
184B5
NM
Basal
PD184352
MEK
MAPK
12566.155
uM
3.29320
33.01680
-0.0750 -1.0000 0.4766 0.2503
0.9170
1.5389
184B5
NM
Basal
PD173074
FGFR1/3
RTK
5897.093
uM
28.42620
33.05570
0.2039 -0.5632 4.9999 0.0088
0.9753
1.2047
184A1
NM
Basal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
5895.085
uM
1.60350
2.04080
-0.6352 -0.4548 2.6820 0.5481
0.9684
1.4396
184B5
NM
Basal
PD 98059
MEK
MAPK
12566.152
uM
inf
inf
0.9069 0.9069 0.0000 0.0066
0.4227
1.4827